Trichophyton indotineae (T. indotineae) often causes persistent, recurrent skin infections and is spreading worldwide. The fact that the number of cases has also increased in Central Europe in recent years is shown, among other things, by an epidemiological study carried out in Germany. As T. indotineae leads to terbinafine-resistant dermatophytoses, timely molecular biological detection of the pathogen is of crucial importance. Itraconazole is currently the most effective drug against dermatophytoses caused by T. indotineae.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- From symptom to diagnosis
Gynecomastia and Adipomastia
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- SURPASS-CVOT
Tirzepatide versus Dulaglutide in T2D with ASCVD
- Secondary prevention after ACS: individually optimized lipid management
Trend towards early combination therapy and new strategies for lowering Lp(a)
- Pediatric Brain Tumors
Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
- What the latest studies on the entire EF spectrum mean for clinical practice
Heart Failure – The 2026 Evidence Update
- Acute ischemic stroke
Alteplase and Tenecteplase Are on the Same Level
- CKD in People with Type 2 Diabetes: Evidence-Based, Optimized Treatment